Detalles de la búsqueda
1.
Antidrug Antibodies in Patients Treated with Alirocumab.
N Engl J Med
; 376(16): 1589-90, 2017 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28304229
2.
Separating the isomers--efficient synthesis of the N-hydroxysuccinimide esters of 5 and 6-carboxyfluorescein diacetate and 5 and 6-carboxyrhodamine B.
Bioorg Med Chem Lett
; 24(14): 3186-8, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24856065
3.
Combined Semi-mechanistic Target-Mediated Drug Disposition and Pharmacokinetic-Pharmacodynamic Models of Alirocumab, PCSK9, and Low-Density Lipoprotein Cholesterol in a Pooled Analysis of Randomized Phase I/II/III Studies.
Eur J Drug Metab Pharmacokinet
; 47(6): 789-802, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35974290
4.
Disappearance of anti-thyroglobulin antibodies from the cerebrospinal fluid in parallel with neurological improvement during treatment for Hashimoto's encephalopathy / Disparition des anticorps anti-thyroglobuline dans le liquide céphalo-rachidien après traitement de l'encéphalopathie de Hashimoto
Ann Biol Clin (Paris)
; 80(5): 464-465, 2022 09 01.
Artículo
en Inglés, Francés
| MEDLINE | ID: mdl-36453744
5.
New iodinated quinoline-2-carboxamides for SPECT imaging of the translocator protein.
Bioorg Med Chem Lett
; 20(3): 954-7, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20045646
6.
Obesity and Preoperative Anaemia as Independent Risk Factors for Sternal Wound Infection After Coronary Artery Bypass Graft Surgery with Pedicled (Non-Skeletonized) Internal Mammary Arteries: The Role of Thoracic Wall Ischemia?
Vasc Health Risk Manag
; 16: 553-559, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33364774
7.
PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study.
J Clin Lipidol
; 14(3): 322-330.e5, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32331936
8.
Vasculitides and glomerulonephritis associated with Staphylocococcus aureus infective endocarditis: cases reports and mini-review of the literature.
Ann Med
; 52(6): 265-274, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32588668
9.
Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial.
J Clin Lipidol
; 14(5): 707-719, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32928709
10.
Population Pharmacokinetic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using a Michaelis-Menten Approximation of a Target-Mediated Drug Disposition Model-Support for a Biologics License Application Submission: Part I.
Clin Pharmacokinet
; 58(1): 101-113, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29725996
11.
Population Pharmacokinetic/Pharmacodynamic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using an Indirect Response Model to Predict Low-Density Lipoprotein Cholesterol Lowering: Support for a Biologics License Application Submission: Part II.
Clin Pharmacokinet
; 58(1): 115-130, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29725997
12.
Relationship between alirocumab, PCSK9, and LDL-C levels in four phase 3 ODYSSEY trials using 75 and 150 mg doses.
J Clin Lipidol
; 13(6): 979-988.e10, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31708410
13.
Severe post-artesunate delayed onset anaemia responding to corticotherapy: a case report.
J Travel Med
; 25(1)2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29394387
14.
Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies.
Clin Pharmacokinet
; 56(10): 1155-1171, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28063030
15.
Relationship Between Low-Density Lipoprotein Cholesterol, Free Proprotein Convertase Subtilisin/Kexin Type 9, and Alirocumab Levels After Different Lipid-Lowering Strategies.
J Am Heart Assoc
; 5(6)2016 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27287699
16.
Corrigendum to PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study Volume 14, Issue 3, May-June 2020, Pages 322-330.e5.
J Clin Lipidol
; 14(5): 741, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33138961
17.
A randomized study of the relative pharmacokinetics, pharmacodynamics, and safety of alirocumab, a fully human monoclonal antibody to PCSK9, after single subcutaneous administration at three different injection sites in healthy subjects.
Cardiovasc Ther
; 32(6): 297-301, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25256660
Resultados
1 -
17
de 17
1
Próxima >
>>